Abstract. In this blog, we provide a comparison between simulation-based and conventional statistical methods, examining their respective principles, applications, strengths, and weaknesses. We provide a simple real-life example to illustrate similarities and...
Choosing the right pharmacokinetic (PK) model is like finding the perfect recipe for a gourmet meal; it requires precision, expertise, and a deep understanding of the ingredients involved. In the world of drug development, PK models are the secret sauce that can make...
At the 2024 DIA Annual Meeting in San Diego, the pharmaceutical and healthcare industries converged on several pivotal reflecting ongoing transformations within the sector. Here are some key themes that dominated discussions: AI in Drug Development: Discussions...
In the journey of drug development, biostatistics emerges as a cornerstone, ensuring that the path from the laboratory bench to the patient's bedside is navigated with precision, efficiency, and scientific rigor. For Phase 1 Clinical Research Organizations (CROs) like...
Refer to Part 1 and Part 2 of this topic series. This blog is based off a poster presentation presented at the ASCPT 2024 annual meeting. To download a PDF version, click here. Clinical studies are, albeit well-controlled, not immune to missing data, and it is crucial...
At BioPharma Services Inc, our story isn't just about groundbreaking medical research; it's a tale of passionate individuals driven by a shared vision to make a real difference in patient lives. Founded by surgeons and led by a team of experts, BioPharma Services is...
